BrightSpring Home Health Expansion | Service Synergies
- BrightSpring Health Services (Nasdaq: BTSG) is prioritizing the expansion of its home-based care programs to enhance synergies across its various service lines.
- Jennifer Phipps, BrightSpring’s executive vice president and chief financial officer, said wednesday at the 46th Annual Goldman Sachs Global Healthcare Conference that the company anticipates continued growth in...
- A core strategy for BrightSpring involves generating quality leads and driving volume growth across all business lines.
BrightSpring Health Services is aggressively expanding its home-based care programs, prioritizing growth in home health care service lines and margins.This strategic move, unveiled at the 46th Annual Goldman Sachs Global Healthcare Conference, includes a keen focus on care coordination to bolster value-based care initiatives, aiming to reduce hospitalizations. With a commitment to strategic acquisitions and a streamlined operational platform, BrightSpring is setting its sights on long-term growth. The CareRx medication management program is a core example, leading to fewer hospitalizations for participating home health patients. Furthermore, the company is exploring opportunities to grow primary care and rehabilitation programs. It’s also worth noting that brightspring’s majority shareholder, KKR & Co., recently announced a secondary offering of shares. News Directory 3 provides insights into these healthcare developments, and the future landscape looks promising. We can expect further developments as BrightSpring continues to refine and expand its services. Discover what’s next for this innovative healthcare provider.
BrightSpring Health services Expands Home-Based Care Programs
BrightSpring Health Services (Nasdaq: BTSG) is prioritizing the expansion of its home-based care programs to enhance synergies across its various service lines. The Louisville, Kentucky-based company aims to grow its home infusion, home-based primary care, and rehabilitation services.
Jennifer Phipps, BrightSpring’s executive vice president and chief financial officer, said wednesday at the 46th Annual Goldman Sachs Global Healthcare Conference that the company anticipates continued growth in its home health care segment, both in terms of service offerings and profit margins.BrightSpring’s home health segment encompasses home health, hospice, primary care, rehab, and personal care services.
A core strategy for BrightSpring involves generating quality leads and driving volume growth across all business lines. The CareRX medication management programme exemplifies this, Phipps noted, leading to fewer hospitalizations among participating home health patients.
Expanding in-home primary care is expected to create further business opportunities, Phipps explained. Primary care physicians and nurse practitioners can identify and address potential issues during home visits, preventing hospitalizations. The company is also focused on growing its rehab program.
BrightSpring is primarily focused on upside value-based care models, proceeding cautiously rather than taking on excessive risk, according to Phipps.The company views its long-term care pharmacy and home infusion pharmacy as notable opportunities for margin improvement.
Alongside service line growth, BrightSpring intends to maintain its M&A activity, focusing on smaller, strategic acquisitions built on long-term relationships. Phipps emphasized the company’s commitment to building relationships with high-quality providers over extended periods.
An investment made three years ago has streamlined brightspring’s acquisition process, Phipps noted. By transitioning to a single operating platform, the company has improved reporting and leveraged its processes and infrastructure more effectively.
Phipps also addressed the recent declaration by KKR & Co. (NYSE: KKR), BrightSpring’s majority shareholder, regarding a secondary offering of 14 million shares of BrightSpring stock, with an option to sell an additional 2.1 million shares. She suggested this news may have contributed to a recent drop in the company’s stock price. If fully executed, KKR would retain just over 44% ownership.
“We have no reason to believe that they wouldn’t be extremely balanced in how they would approach an exit of BrightSpring, but they continue to be very supportive of our company, the growth track record, and ultimately, what we are going to deliver as a company,” Phipps said.
What’s next
BrightSpring aims to continue expanding its home-based care services, focusing on home health care growth and care coordination to drive value-based care outcomes and improve patient results.